Busulfan
DrugBank ID: DB01008
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| myelodysplastic syndrome | 0.9962 | DL |
| refractory cytopenia of childhood | 0.9954 | DL |
| unclassified myelodysplastic syndrome | 0.9953 | DL |
| partial deletion of the long arm of chromosome 5 | 0.9951 | DL |
| aregenerative anemia | 0.9949 | DL |
| severe congenital hypochromic anemia with ringed sideroblasts | 0.9949 | DL |
| HIV infectious disease | 0.9944 | DL |
| neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | 0.9922 | DL |
| seborrheic keratosis | 0.9916 | DL |
| feline acquired immunodeficiency syndrome | 0.9906 | DL |
| simian immunodeficiency virus infection | 0.9906 | DL |
| rheumatoid arthritis | 0.9904 | DL |
| obsolete familial combined hyperlipidemia | 0.9902 | DL |
| female breast carcinoma | 0.9886 | DL |
| primary cutaneous T-cell lymphoma | 0.9884 | DL |
| vulvar inverted follicular keratosis | 0.9875 | DL |
| multiple sclerosis | 0.9867 | DL |
| granulomatous slack skin disease | 0.9858 | DL |
| seborrheic dermatitis | 0.9852 | DL |
| Crohn's colitis | 0.9844 | DL |
| hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | 0.9831 | DL |
| sickle cell-beta-thalassemia disease syndrome | 0.9831 | DL |
| sickle cell-hemoglobin E disease syndrome | 0.9831 | DL |
| sickle cell-hemoglobin c disease syndrome | 0.9831 | DL |
| sickle cell-hemoglobin d disease syndrome | 0.9831 | DL |
| autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | 0.9826 | DL |
| brachydactyly-syndactyly syndrome | 0.9822 | DL |
| brain small vessel disease 1 with or without ocular anomalies | 0.9820 | DL |
| rhabdomyosarcoma (disease) | 0.9816 | DL |
| folliculotropic mycosis fungoides | 0.9812 | DL |
| colobomatous microphthalmia-rhizomelic dysplasia syndrome | 0.9798 | DL |
| progressive relapsing multiple sclerosis | 0.9791 | DL |
| cholecystolithiasis | 0.9787 | DL |
| parameningeal embryonal rhabdomyosarcoma | 0.9786 | DL |
| botryoid-type embryonal rhabdomyosarcoma of the vagina | 0.9784 | DL |
| extrahepatic bile duct rhabdomyosarcoma | 0.9783 | DL |
| gout | 0.9783 | DL |
| lipoid nephrosis | 0.9779 | DL |
| gastric linitis plastica | 0.9778 | DL |
| prostate embryonal rhabdomyosarcoma | 0.9778 | DL |
| embryonal extrahepatic bile duct rhabdomyosarcoma | 0.9776 | DL |
| diabetic nephropathy | 0.9773 | DL |
| refractory hematologic cancer | 0.9748 | DL |
| psoriasis | 0.9746 | DL |
| dermatofibrosarcoma protuberans | 0.9744 | DL |
| primary cutaneous T-cell non-Hodgkin lymphoma | 0.9742 | DL |
| liver sarcoma | 0.9740 | DL |
| eye disease | 0.9734 | DL |
| presbyopia | 0.9728 | DL |
| chronic relapsing inflammatory optic neuropathy | 0.9723 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.